These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34841735)

  • 1. Deep phenotyping of T cell populations under long-term treatment of tacrolimus and rapamycin in patients receiving renal transplantations by mass cytometry.
    Li Y; An H; Shen C; Wang B; Zhang T; Hong Y; Jiang H; Zhou P; Ding X
    Clin Transl Med; 2021 Nov; 11(11):e629. PubMed ID: 34841735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin and tacrolimus differentially modulate acute graft-versus-host disease in rats after liver transplantation.
    Xu G; Wang L; Chen W; Xue F; Bai X; Liang L; Shen X; Zhang M; Xia D; Liang T
    Liver Transpl; 2010 Mar; 16(3):357-63. PubMed ID: 20209637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
    Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
    Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes in rapamycin on renal allograft function: a 30-year follow-up from a single-center experience.
    Ji Y; Sun L; Fei S; Gao X; Chen H; Han Z; Tao J; Ju X; Wang Z; Tan R; Gu M
    BMC Nephrol; 2024 Sep; 25(1):311. PubMed ID: 39294598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey.
    Qi S; Xu D; Peng J; Vu MD; Wu J; Bekersky I; Fitzsimmons WE; Peets J; Sehgal S; Daloze P; Chen H
    Transplantation; 2000 Apr; 69(7):1275-83. PubMed ID: 10798741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients.
    Segundo DS; Ruiz JC; Izquierdo M; Fernández-Fresnedo G; Gómez-Alamillo C; Merino R; Benito MJ; Cacho E; Rodrigo E; Palomar R; López-Hoyos M; Arias M
    Transplantation; 2006 Aug; 82(4):550-7. PubMed ID: 16926600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus.
    Lemahieu WP; Maes BD; Verbeke K; Vanrenterghem Y
    Am J Transplant; 2004 Sep; 4(9):1514-22. PubMed ID: 15307840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients.
    Rostaing L; Puyoo O; Tkaczuk J; Peres C; Rouzaud A; Cisterne JM; de Preval C; Ohayon E; Durand D; Abbal M
    Clin Transplant; 1999 Oct; 13(5):400-9. PubMed ID: 10515221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of in vivo rapamycin treatment on de novo T-cell development in relation to induction of autoimmune-like immunopathology in the rat.
    Damoiseaux JG; Beijleveld LJ; Schuurman HJ; van Breda Vriesman PJ
    Transplantation; 1996 Oct; 62(7):994-1001. PubMed ID: 8878395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar early complication rate in simultaneous pancreas and kidney recipients on tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus immunosuppressive regimens.
    Girman P; Lipar K; Koznarova R; Boucek P; Kriz J; Kocik M; Havrdova T; Adamec M; Saudek F
    Transplant Proc; 2010; 42(6):1999-2002. PubMed ID: 20692391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of rapamycin versus FK506 on expression of cytoprotective genes in the rat kidney allografts undergoing chronic allograft nephropathy.
    Teng D; Lu Y; Gao R; Xin Y; Cao G; Li X; Wang L; Wang J; Li Y
    Transplant Proc; 2006 Sep; 38(7):2172-5. PubMed ID: 16980034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus.
    Gallon L; Traitanon O; Sustento-Reodica N; Leventhal J; Ansari MJ; Gehrau RC; Ariyamuthu V; De Serres SA; Alvarado A; Chhabra D; Mathew JM; Najafian N; Mas V
    Kidney Int; 2015 Apr; 87(4):828-38. PubMed ID: 25354238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
    Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of vincristine with tacrolimus or sirolimus in prevention of acute heart allograft rejection in the rat.
    Jiang W; Jiang J; Xu D; Wang X; Qi S; Ouyang J; Ma A; Vu MD; Bilolo KK; Chen H
    Microsurgery; 2003; 23(2):117-22. PubMed ID: 12740883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation Between Immunosuppressive Therapy and CD4(+) T-Cell Intracellular Adenosine Triphosphate Levels in Liver Transplant Recipients.
    Qu W; Zhu ZJ; Sun LY; Wei L; Liu Y; Zeng ZG
    Transplant Proc; 2016; 48(6):2094-7. PubMed ID: 27569951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression With CD40 Costimulatory Blockade Plus Rapamycin for Simultaneous Islet-Kidney Transplantation in Nonhuman Primates.
    Oura T; Hotta K; Lei J; Markmann J; Rosales I; Dehnadi A; Kawai K; Ndishabandi D; Smith RN; Cosimi AB; Kawai T
    Am J Transplant; 2017 Mar; 17(3):646-656. PubMed ID: 27501203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells.
    Cho CS; Chang Z; Elkahwaji J; Scheunemann TL; Manthei ER; Colburn M; Knechtle SJ; Hamawy MM
    Int Immunol; 2003 Nov; 15(11):1369-78. PubMed ID: 14565935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
    Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
    Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.